IN BRIEF: Renalytix AI's KidneyIntelX A Fixture In New York Hospitals

Renalytix AI PLC - Cardiff, Wales-based clinical diagnostics company - Reports commercial launch ...

Alliance News 18 September, 2020 | 8:17PM
Email Form

Renalytix AI PLC - Cardiff, Wales-based clinical diagnostics company - Reports commercial launch of KidneyIntelX clinical test reporting platform in New York City's Mount Sinai Health System hospital network. Platform helps risk assess a patient's progressive decline in kidney function.

Current stock price: 522.30 pence

Year-to-date change: up 43%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Renalytix AI PLC 422.30 GBX -2.92 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies